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Effects of matrix glycation on mesangial cell adhesion, spreading and
proliferation. We examined the effects of in vitro nonenzymatic glycosy-
lation (NEG) of the extracellular matrix (ECM) on various aspects of the
adhesive interaction between the ECM and human kidney mesangial
(HKM) cells, and also on the ability of HKM cells to spread and
proliferate, Isolated type IV collagen (tIV) or intact complexes of
glomerular basement membrane and mesangial matrix (GBMIIvIM) were
used as substrates following control incubation or modest glycation. We
observed that HKM cells adhered less effectively to glycated tIV at early
time intervals and were delayed in attaining maximal levels of adhesion
compared to cells interacting with control tIV. The nature of the adhesive
interaction was also different since antibodies which blocked the function
of i31-containing integrins more effectively inhibited adhesion between
HKM cells and glycated tIV than cells and control tIV. HKM cells
interacting with glycated tIV also demonstrated less cell surface micro-
spike and ruffle formation at five minutes after plating, less extensive
spreading throughout the examined time intervals ( 90 mm after
plating), and slightly increased cell numbers 5 to 10 days after plating
when compared to cells interacting with control tIV. However, increased
cell numbers were not observed when HKM cells were grown on glycated
GBM/MM. Similar changes in response to glycated substrate were ob-
served when HKM cells were grown in either S or 25 m glucose. In
conclusion, relatively modest glycation of the ECM alone was sufficient to
result in specific changes in HKM cell behavior in vitro. It is possible that
the matrix glycation which occurs in the kidneys of diabetic patients could
alter mesangial cell behavior in situ in ways which may contribute to the
development of diabetic nephropathy.
Expansion of the glomerular mesangium correlates with declin-
ing renal function in diabetic patients [1, 2]. Morphometric studies
have determined that this expansion is primarily due to an
accumulation of mesangial matrix (MM) while an increase in the
cellular component of the mesangium contributes only slightly [3].
Since mesangial cells are the cells primarily responsible for MM
production and turnover, their behavior, and the influence of the
diabetic milieu on this behavior, might play an important role in
the development of diabetic nephropathy. It has been shown that
restoration of euglycemia as a result of pancreatic transplantation
causes an arrest or reversal of mesangial expansion and amelio-
rates renal dysfunction [4, 5]. In addition, the Diabetes Control
and Complications Trial Research Group recently provided evi-
dence directly linking strict glycemic control to the prevention of
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various diabetic complications including nephropathy [6]. There-
fore, research efforts have focused on delineating the mecha-
nism(s) by which hyperglycemia could lead to the altered renal
structure and function observed in diabetic kidney disease.
Nonenzymatic glycosylation (glycation: NEG) of long-lived
proteins, such as those of the MM, is one of several mechanisms
by which hyperglycemia may lead to the pathogenesis of diabetic
nephropathy. At the molecular level, NEG begins with the
spontaneous and reversible condensation of a reducing sugar with
a free amino group, usually the E-amino group of a lysine residue.
The resulting Schiff base may undergo Amadori rearrangement to
form a ketoamine adduct which can then condense with an
adjacent ketoamine adduct or amino acid side chain to form an
irreversible crosslink product known as an advanced glycation
endproduct (AGE) [7]. This series of reactions occurs normally in
vivo and become highly accelerated under the hyperglycemic
conditions of diabetes [8]. Additionally, the accumulation of
NEG-adducts in the tissues of diabetic patients correlates with the
development of various diabetic complications including diabetic
nephropathy [9, 10].
Mesangial cells are involved in a dynamic interrelationship with
their surrounding extraceilular matrix (ECM), in this case the
mesangial matrix (MM). The cells produce and modify the ECM
and the ECM in turn influences and regulates cell behavior by
interacting with and signaling through specific cell surface recep-
tors, including integrins [11, 12]. Thus, the composition and
structure of the ECM can influence various aspects of cell
phenotype and function [13—15]. It has been established that
glycation alters the structure and function of ECM proteins,
including isolated tIV [16—18], and it has recently been shown to
alter the ultrastructure of intact renal basement membrane [19].
In view of this, it is possible that NEG-induced modification of the
MM could influence mesangial cell/MM interactions and causes
changes in mesangial cell behavior which contribute to the
development of diabetic nephropathy.
Several reports have attempted to examine the effect of ECM
glycation on mesangial cell behavior [20, 21]. However, they have
used levels of glycation which may be 10 to 40 times more
extensive than those observed in the tissues of patients with even
severe diabetic complications [9]. In addition, they have used as a
substrate ECM produced by mesangial cells in culture. This
matrix is composed primarily of collagen types I and III [22],
components which are not present in the normal mesangium [23,
24]. In this report, we have used as a substrate either an intact
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complex of glomerular basement membrane/mesangial matrix
(GBM/MM) or isolated intact tIV, the most abundant component
of the MM [25], in order to more closely approximate the
environment of mesangial cells in situ. In addition, we have used
moderate levels of substrate glycation which should more closely
resemble that of diabetic patients during the period when char-
acteristic changes in renal structure and function might develop
[9].
Methods
Substrate preparation
In vitro glycation of type IV collagen. Type IV collagen, isolated
from the EHS tumor system, was glycated using previously
described techniques [17]. Briefly, tIV was incubated for two days
at 29°C in buffer solutions containing PBS (pH 7.4), 0.5 M NaC1
(final salt concentration 0.65 M), 10mM EDTA, 1 mivi PMSF, 1 mM
N-ethylmaleimide (NEM), 0.02% sodium azide, and one of the
following: buffer only, in the absence of glucose (tIV-0), 50 mM
glucose (tIV-50), or 500 m glucose (tIV-500). These conditions
resulted in the addition of none, 1, or 10 moles of glucose per
mole of tIV, respectively [17]. The fluorescence of each sample
was measured at the excitation/emission wavelength of 370/440
nm using a luminescence spectrometer (Model LS 50 B; Perkin
Elmer, St. Louis, Missouri, USA) interfaced with a microcom-
puter (Model 6382; IBM Corp., Armonk, New York, USA).
Measurement of fluorescence at this wavelength is routinely used
to detect AGE adducts [8] and revealed only a minimal increases
of 3 and 8% for tIV-50 and tIV-500, respectively, compared to
control incubated tIV-0. To induce more extensive NEG and
AGE formation with in vitro glycation, tIV was incubated for five
days at 29°C in solutions containing 0.2 M phosphate buffer (pH
7.4), 0.3 M NaCI (final salt concentration 0.5 NI), 10 mrvi EDTA, 1
mM PMSF, 1 mri NEM, 0.02% sodium azide, and one of the
following: buffer only, in the absence of glucose (control tIV-C),
500 m glucose (tIV-G), or 500 m'vi ribose (tIV-R). Ribose has
been reported to be 16.6 times more reactive than glucose in the
formation of Schiff base products with proteins [26] and 129 times
more reactive in the generation of AGEs [27]. Fluorometric
analysis revealed a 13% and 551% increase in fluorescence at
370/440 nm for tIV-G and tIV-R, respectively, compared to
control incubated tIV-C.
Isolation and glycation of GBMIMM Renal glomeruli were
harvested from calf kidneys using the technique of Butkowski and
Hagen [28]. The GBM/MM complex was then isolated from these
glomeruli using a previously described detergent extraction tech-
nique [19, 29]. Briefly, cells were lysed in a large (100:1) volume of
5 mM Tris-HC1, 0.02% sodium azide, 1 mti EDTA, 1 mrvi NEM, 1
mM PMSF, pH 7.4 at 4°C, Crude GBM/MM was washed once with
a solution of PBS, 0.02% sodium azide, 1 ifiM EDTA, 1 mMNEM,
1 mM PMSF, resuspended to 15 times the original tissue volume
in 4% deoxycholic acid, 0.02% sodium azide, 1 mri EDTA, 1 mM
NEM, 1 m PMSF, and incubated 2.5 hours at 37°C. Following
extraction with detergent, GBM/MM was washed three times in
PBS, 0.02% sodium azide, resuspended to five times the original
tissue volume in PBS, deoxyribonuclase A (50 Kunitz U/ml),
0.02% sodium azide, and incubated one hour at 37°C. GBM/MM
was then washed three times in PBS, 0.02% sodium azide, 1 m
EDTA, 1 mi NEM, 1 mi PMSF, aliquotted, and stored at —80°C
for future use. Western blot analysis of extracts from these
structures demonstrated the major GBM/MM components in-
cluding tIV, laminin, and entactin/nidogen (data not shown).
Before incubating in the presence or absence of reducing
sugars, GBM/MM in PBS, 0.02% sodium azide, 1 mrvi EDTA, 1
mM NEM, 1 mi PMSF were disrupted into small fragments using
12 x 10 second treatments at a power setting of 6 with a sonic
tissue disrupter fitted with a micro tip (Model 250 Sonifier;
Branson Ultrasonics Corp., Danbury, Connecticut, USA). Sam-
ples were maintained on ice at all times and allowed to cool for
two minutes between treatments. Very large fragments were
removed by centrifugation at 1500 rpm for five minutes. The
supernatant containing small fragments of GBM/MM was incu-
bated for five days at 29°C in solutions containing 0.2 NI phosphate
buffer (pH 7.4), 1 mrvi EDTA, 1 mi PMSF, 1 mrvi NEM, 0.02%
sodium azide, and one of the following: no sugar (control:
GBM-C), 500 m glucose (GBM-G), or 500 m ribose (GBM-R).
Fluorometric analysis at 370/440 nm revealed a 31% and 560%
increase in fluorescence for GBM-G and GBM-R, respectively,
compared to control incubated GBM-C.
Coating of tissue culture plastic. Following incubation, samples
were dialyzed against PBS (pH 7.4), the protein concentration of
each sample was determined using the method of Waddell [30],
and the extent of glycation was measured by fluorescence at
370/440 nm to ascertain for similar levels of modification among
experiments. Samples were then diluted to appropriate coating
concentrations and 50 p3 aliquots were pipetted into the wells of
96-well microtiter plates (Immulon 1 or Microlite 1; Dynatech
Laboratories Inc., Chantilly, Virginia, USA) and allowed to
evaporate to dryness at 29°C. Upon drying, 200 l.tl of sterile 0.2%
BSA (Fraction V; ICN Biomedicals Inc., Aurora, Ohio, USA) in
PBS (pH 7.4) was added to each well and the plates were
incubated in a humidified incubator for two hours at 37°C in order
to block remaining reactive sites on the plastic. Plates were then
washed once with sterile PBS (pH 7.4) and immediately used for
experiments. Plates which were used for proliferation assays were
sterilized by UV irradiation prior to blocking with 0.2% BSA in
PBS. The coating concentration of each control or differentially
glycated sample was adjusted according to its ability to adsorb to
Immulon #1 and Microlite #1 plastic under the coating condi-
tions described above. The coating efficiency was previously
determined by the use of radiolabled proteins (1251-tIV or 125j.
GBM/MM) in solid phase adhesion assays [17] and the BCA
protein determination technique in the wells of the microtiter
plates (Micro BCA; Pierce, Rockford, Illinois, USA).
Cell culture
Human kidney mesangial (HKM) cells. HKM cells were isolated
from fetal tissue as previously described [31]. Cells were cultured
at 37°C in an environment of 95% air and 5% CO2 and in media
composed of DMEM containing either 5 m glucose (normogly-
cemic) or 25 m glucose (hyperglycemic), 20% FBS, 15 mtvi
HEPES, penicillin (100 U/mI), streptomycin (100 Lg/ml), and
amphotericin (25 Lg/ml). Cells were released from their tissue
culture flasks for passaging or use in experiments, by washing
twice with 1 ffiM EDTA in HBSS and then treating with 0,05%
Trypsin and 1 mM EDTA in HBSS for one minute. Cells between
passage 4 and 9 were used in experiments.
Assays
Adhesion. HKM cells were metabolically labeled by incubating
in growth media containing 0.8 mCi 35S-methionine for 18 hours.
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They were then released from the tissue culture flask, washed
three times with DMEM, resuspended in 0.02% BSA, 15 m'vi
HEPES, and DMEM, and seeded into 96-well plates (5000
cells/well) coated with either tIV-0, tIV-50, and tIV-500 at three
different protein densities (0.72, 0.24, or 0.08 pmol/cm2); tIV-C,
tIV-G, and tIV-R at two different protein densities (0.6 or 1.2
pmol/cm2); or GBM-C, GBM-G, and GBM-R at two different
protein densities (mass equivalent of 0.6 or 1.2 pmol/cm2 tIV).
After 15, 30, 60, or 120 minutes, non-adherent or weakly-adherent
cells were removed by washing three times with 200 d of 0.2%
BSA, 15 m'vi HEPES, and DMEM (pH 7.4) using a multichannel
pipetter. After washing, 100 tl of scintillation fluor (Microscint
20; Packard Instrument Company, Inc., Meriden, Connecticut,
USA) was added to each well, plates were sealed with heat sealing
film (TopSeal-S; Packard) using a microplate heat sealer (Micro-
Mate 496; Packard), and the percentage of cells which had
remained adherent was determined by scintillation count using a
microplate scintillation counter (TopCount; Packard). Results
were expressed as the mean SD of 7 replicates.
Antibody inhibition of cell adhesion. Metabolically labeled HKM
cells were seeded onto 96-well plates (5000 cells/well) coated with
tIV-0, tIV-50, and tIV-500 at a protein density of 0.24 pmol/cm2.
Some wells also contained varying amounts of a monoclonal
antibody (0,0 to 8.0 tg/ml) which specifically binds to and inhibits
the function of f31-containing integrins (P5D2: a gift of Dr.
Elizabeth Wayner, University of Minnesota, Minneapolis, MN,
USA). A monoclonal antibody which binds cell surface HLA
molecules was used as a control (W6/32, HB 95: American Type
Culture Collection, Rockville, Maryland, USA). After 45 minutes,
non-adherent or weakly adherent cells were removed and adher-
ent cells were quantitated as described above. Results, expressed
as a percentage of maximal binding, represent the mean SD of
five replicates.
SEM analysis of initial interaction with substrate. HKM cells were
seeded into 96-well plates (5000 cells/well) coated with either
tIV-0, tIV-50, or tIV-500 (0.24 pmol/cm2). After five minutes, cells
were gently washed three times with 140 m sodium cacodylate
(pH 7.4), fixed for 15 minutes in 1% paraformaldehyde, 1%
glutaraldehyde, and 140 m sodium cacodylate (pH 7.4), washed
with 140 m sodium cacodylate (pH 7.4), and post-fixed in a
solution of 1.3% osmium tetroxide and 140 m sodium cacodylate
(pH 7.4) for 15 minutes on ice. Samples were then prepared for
examination using a low voltage scanning electron microscope
(LV-SEM) as described elsewhere [19]. Briefly, samples were
washed in deionized water, dehydrated in a graded series of
increasing ethanol concentrations, dried using a critical point
drying apparatus (Samdri Model 708A; Tousimis Research Corp.,
Rockville, Massachusetts, USA), coated with —10 A platinum
using an ion beam microsputter system (Model 705; VCR Group,
Inc., San Francisco, California, USA) operating at 10 kV and 4
mA for six minutes. Coated samples were stored in a desiccated
chamber prior to examination with a Hitachi S-900 high resolution
LV-SEM (Nisser Sangyo America, Ltd., Mountain View, Califor-
nia, USA) operating at an accelerating voltage of 2 kV [32].
Each cell on the various substrates was categorized into one of
the following three populations according to cell surface morphol-
ogy: (+ +) extensive cell surface ruffling, (+)small amounts of cell
surface ruffling, and (—) no cell surface ruffling. A minimum of
100 cells from each of three wells were analyzed per substrate.
The percentage of cells demonstrating the various cell surface
morphologies was calculated for each well. Results were ex-
pressed as the mean SD of quadruplicates.
Spreading. HKt'vI cells were seeded into 96-well plates (2000
cells/well) coated with either tIV-0, tIV-50, or tIV-500 at a density
of 0.24 pmol/cm2. After either 30, 60, or 90 minutes, cells were
washed one time with PBS (pH 7.4), fixed and stained with a
Diff-Quik staining set (Baxter Scientific Products, McGaw Park,
Illinois, USA), and analyzed using a light microscope (Model
D-7082; Zeiss, Oberkochen, Germany) connected to a video
imaging system (Optomax, Inc., Hollis, New Hampshire, USA)
which was interfaced with a microcomputer (Apple lie; Cuper-
tino, California, USA). Using this apparatus, the surface area and
perimeter of a minimum of 100 cells from each of four wells per
substrate were measured for cells which had interacted with each
substrate for either 30 minutes or 60 minutes. Results were
expressed as the mean SD of the values from each of the four
wells.
Following 90 minutes of interaction with the substrate, exten-
sive spreading of some cells made accurate analysis difficult using
the previously described system. Therefore, an alternative method
of assessing cell spreading characteristics was used. Individual
cells were observed by light microscopy and categorized into one
of three groups according to their spreading characteristics: (+ +)
asymmetrical spreading with extensive cytoplasmic extensions and
apparent stress fiber formation, (+) symmetrical spreading with
cytoplasmic extensions, and (—) symmetrical spreading with no
cytoplasmic extensions. At least 100 cells were analyzed from each
of four wells for each substrate. Results for each substrate were
expressed as the mean SD of quadruplicates. Cells demonstrat-
ing representative spreading morphologies were photographed
using an interference reflectance microscope (Model 1M35:
Zeiss). At later time intervals, cell morphology on control and
glycated tIV was observed in culture using brightfield and phase
contrast microscopy (Wilovert II Ph: Hund, Wetzlar, Germany).
Proliferation. The effect of substrate glycation on mesangial cell
proliferation was determined by counting the number of cells
which accumulated during 2 to 10 days of culture with the various
substrates. Techniques which measured DNA content as an
indirect indicator of the number of cells in culture, or which
depended on the incorporation of radiolabled nucleotides into
newly synthesized DNA as an indicator of cell proliferation were
avoided, since these methods may be sensitive to changes in cell
cycle and ploidy. Recently, similar changes have been reported for
cells isolated from the tissues of diabetic patients, suggesting that
DNA-detecting techniques may yield misleading results when
used to examine the effect of diabetic conditions on cell growth
and proliferation [33].
In this report, proliferation/cell counting assays were performed
using HKM cells which had been treated in one of the following
ways prior to the experiment: (1) cells were maintained in normal
growth medium, (2) cells were rested in 1% FBS for 72 hours, or
(3) cells were synchronized at S phase by sequential treatment
with growth media containing 1% FBS for 48 hours, normal
growth medium for six hours, and finally growth medium contain-
ing 1.25 mri hydroxyurea for 12 hours. In each instance, cells were
then released, washed two times in media containing 1% FBS,
resuspended in the same media, and then seeded into the wells of
UV-sterilized 96-well plates (2000 cells/well) coated with either
tIV-C, tIV-G, and tIV-R (1.2 pmol/cm2) or GBM-C, GBM-G, and
GBM-R (mass equivalent of 1.2 pmol/cm2 tIV). in all instances,
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5 25Fig. 1. HKM cell adhesion to control or glycated tThC 35S-methionine-
labeled HKM cells cultured in media containing 25 mti glucose were
seeded into 96-well plates (5000 cells/well) coated with tIV (0.24 pmol/
cm2) which had been previously incubated in the absence of sugar (tlV-0:
—0—) or in the presence of either 50 (tIV-50: —e--) or 500 mivi glucose
(tIV-500: ---s---) for 2 days at 29°C. After 15, 30, 60, or 120 minutes,
non-adherent or wealdy adherent cells were removed and adherent cells
were quantitated. Results are expressed as mean SD of8 replicates and
were analyzed using single-factor analysis of variance and Newman-Keuls
multiple range tests (P C 0.05: * ANOVA; t tIV-0 vs. tIV-500; tIV-0 vs.
tIV-50; § tIV-50 vs. tIV-500).
viability of the HKM cells at this point was determined to be
>95% by trypan blue exclusion assay. After incubation for two
hours at 37°C which resulted in maximal and equivalent HKM cell
adhesion to the various substrates, an equal volume of growth
media containing 38% FBS was added to each well to give a final
concentration of all media components which was identical to
normal growth media. The plates were then incubated 2 to 10 days
with biweekly media changes. At specific time intervals, wells were
washed twice with 200 M1 of 1 msn EDTA in PBS and cells were
released by treating with 100 M1 of 0.05% trypsin, 1 mist EDTA in
HBSS for 20 minutes. The resulting single cell suspension from
each well was transferred to individual cell counting vials (Dilu-
Vial; Fisher Scientific Co., Pittsburgh, Pennsylvania, USA) con-
taining 8 ml of isotonic diluent (Hematoll; Fisher) and counted
using an automated cell counter (Model ZM; Coulter Diagnostics,
Hialeah, Florida, USA). Results were expressed as the mean so
of eight replicates.
Statistical analysis
In all experiments the effect of glycation on cell appearance/
behavior was analyzed by single-factor analysis of variance
(ANOVA). Additionally, the Newman-Keuls multiple range test
was used to compare the differences between all possible pairs of
means within each experiment. Where experiments were per-
formed in parallel using cells grown in 5 and 25 m glucose, the
effects of both substrate glycation and the level of glucose in the
media were analyzed by two-factor ANOVA.
Results
Adhesion
Adhesion of HKM cell to tIV, which had been previously
control-incubated or glycated with either 50 or 500 m glucose,
was quantified after 15, 30, 60, or 120 minutes of cell/substrate
interaction. Figure 1 demonstrates that fewer HKM cells adhered
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Fig. 2. Inhibition of HKM adhesion to control or glycated tIV using anti-
bodies against 31-containing integrins. 35S-methionine-labeled HKM cells
cultured in media containing either 5 or 25 m glucose were seeded into
96-well plates (5000 cells/well) coated with tIV (0.24 pmol/cm2) which had
been previously incubated in the absence of sugar (tIV-0: 0) or in the
presence of either 50 (tIV-50: 9) or 500 m glucose (tIV-500: ) for 2
days at 29°C. A monoclonal antibody against f31-containing integrins(PSD2) was included in experimental wells (0.5 jig/mI) in order to
compete with the tIV substrates for binding to HKM cell surface
receptors. A monoclonal antibody against cell surface HLA (W6/32) was
used as a control and had no effect on cell binding. After 45 minutes,
non-adherent or wealdy adherent cells were removed and adherent cells
were quantitated. Each value, presented relative to the maximal level of
adhesion achieved in the absence of competing antibody, represent the
mean 5D of 5 replicates. Single-factor analysis of variance and Newman-
Kuels multiple range tests were performed independently on the results
for cells grown in either 5 or 25 m glucose to determine if the effect of
trY glycation on cell behavior was significant (*P C 0.05 ANOVA; t PC
0.05 tIV-0 vs. tJV-500; P C 0.05 tIV-0 vs. tIV-50; § P C 0.10 tIV-0 vs.
tIV-50). Two-factor analysis of variance determined that glycation and the
level of glucose in the media each significantly altered cell behavior (P C
0.05).
to glucose modified trY compared to control tIV. In all instances,
the observed decrease in adhesion was related to the extent of tIV
glycation since cells adhered most effectively to control tIV
(tIV-0), less to tIV which was pretreated with 50 mist glucose
(tIV-50), and even less to tIV pretreated with 500 mist glucose
(tIV-500). This effect was more prominent at early time intervals
(s60 mm) and was apparently overcome at later time intervals
(120 mm) when HKM cell adhesion to glycated tIV approached
the level of adhesion to control. The effect of glycation on
adhesion was similar for HKM cells which were grown in either 5
or 25 m glucose (data not shown). This was despite the fact that
the level of glucose in the culture media also influenced HKM cell
adhesion slightly: cells grown in 25 m glucose attained —10%
higher level of maximal adhesion compared to those grown in 5 mM
glucose. Two-factor ANOVA determined that the effect of substrate
glycation on cell adhesion was significant and independent from the
level of glucose in the media. Comparable results were obtained
when intact (IBM/MM was used as a substrate (data not shown).
Antibody inhibition of cell adhesion
The differences in the number of cells able to adhere to the
various substrates under our experimental conditions suggested
that glycation could alter interactions between HKM cells and
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Morphology of cell spreading
Fig. 3. HKM cell surface appearance after interaction with control of glycated tIV HKM cells cultured in 25 m glucose were seeded into 96-well plates
(5000 cells/well) coated with tIV (0.24 pmol/cm2) which had been previously incubated in the absence of sugar (tIV-0: E) or in the presence of either
50 (tIV-50, D) or 500 m glucose (tIV-500: U) for 2 days at 29°C. After 5 minutes, cells were fixed and processed for examination using a LV-SEM.
A minimum of 100 cells in each of 4 wells per substrate were analyzed for cell surface morphology: (A: + +) extensive cell surface ruffling, (B: +) small
amounts of cell surface ruffling, and (C: —) no cell surface ruffling. The percentage of cells demonstrating the various cell surface morphologies was
expressed as the mean SD. Results were analyzed using single-factor anlaysis of variance and Newman-Keuls multiple range tests (*P < 0.05; bar
tIV. The major class of cell surface receptors used by HKM cells
to interact with MM components, including tIV, is p1-containing
integrins [11, 12]. To further explore the effect of substrate
glycation on HKM cell/tIV interactions, we used a monoclonal
antibody (P5D2) to block the function of p1-containing integrins
and compete with the tIV substrate for binding to HKM cell
surface receptors. In all instances, the P5D2 antibody inhibited
the adhesion between HKM cells and tIV in a dose dependent
manner and caused —100% inhibition at high antibody concen-
trations (> 4 g/ml). A monoclonal antibody which bound cell
surface HLA molecules was used as a control in these experiments
and did not affect binding between HKM cells and tIV at any of
the concentrations used. As shown in Figure 2, the P5D2 antibody
more effectively competed for the adhesion between HKM cells
and glycated tIV than for the adhesion between cell and control
tIV. This was true for cells grown in either 5 or 25 m glucose.
Again, the level of glucose in the media also had some effect on
cell behavior: the anti-131-integrin antibody was more effective (up
to 29%) at interfering with the adhesion of HKM cells grown in 5
m glucose compared to those grown in 25 m glucose. However,
two-factor ANOVA again determined that the effect of substrate
glycation was significant and independent from the level of
glucose in the media.
SEM analysis of HKM cell surface moiphology
In order to assess whether altered interactions between HKM
cells and glycated tIV may influence cell behavior, LV-SEM was
used to examine the extent of microspike and ruffle formation on
the surface of HKIvI cells five minutes after being seeded on
control or glycated tIV. Microspikes and ruffles are specialized
plasma membrane structures which apparently play a role in the
adhesion, spreading, and locomotion of cells on solid substrate
[34]. They are rapidly induced by various extracellular stimuli
which, through incompletely understood signal transduction path-
ways, promote the active polymerization of actin filaments at the
plasma membrane [35]. As can be seen in Figure 3D, more cells
on control tIV demonstrated extensive microspike and ruffle
formation (Fig. 3A: + +) compared to cells interacting with tIV
which had been glycated with either 50 or 500 mM glucose. In
addition, more cells on glycated tIV demonstrated a rounded or
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Fig. 4. HKIvI cell spreading on control or
glycated tlV. HKM cells cultured in 25 mM
glucose were seeded into 96-well plates (5000
cellstwell) coated with tIV (0.24 pmol/cm2)
which had been previously incubated in the
absence of sugar (tIV-0: B) or in the presence
of either 50 (tIV-50: 0) or 500 m glucose
(tIV-500: U) for 2 days at 29°C. After 30 or 60
minutes, cells were fixed, stained, and cell
surface areas (A) and perimeters (B) were
measured for a minimum of 100 cells in each of
4 wells per substrate. Results were expressed as
mean SD and analyzed using single-factor
analysis of variance and Newman-Keuls
multiple range tests (*P < 0.05).
"blebbed" conformation with an absence of microspikes (Fig. 3C:
—) compared to cells on control tIV. The proportion of cells
demonstrating either a "ruffled" or "blebbed" appearance was
apparently dependent on the extent of tIV glycation.
Spreading
To determine if glycation also altered cell behavior at later time
intervals, the extent of HKM cell spreading was determined after
30 or more minutes of interaction with control or glycated tIV.
After 30 or 60 minutes, cell spreading was quantitated by mea-
suring cell perimeter and cell surface area. Each measurement
detected significantly less cell spreading on glycated tIV compared
to the control, and the degree of impairment was related to the
extent of tIV glycation (Fig. 4). At 90 minutes, cell spreading on
the different substrates was determined by assessing the morphol-
ogy of extensively spread HKM cells. Significantly more cells
demonstrated extensive, asymmetrical patterns of spreading (Fig.
5A: + +) when incubated for 90 minutes on control tIV than on
either of the glycated substrates (Fig. 5). Similar differences
seemed to persist at later time intervals; however, the increasing
complexity of cell appearance and more frequent cell overlapping
made measurements difficult at time points longer than 90
minutes (data not shown).
Proliferation
To examine whether glycation of the substrate had an effect on
other long-term aspects of cell behavior, we examined the prolif-
eration of HKM cells which had been plated on control and
glycated tIV by measuring cell numbers in long-term culture.
Beginning at five days after plating, and extending through the
duration of the experiment, cells grown on tIV which had been
previously incubated with 500 m glucose for five days demon-
strated small but statistically significant increases in their numbers
compared to cells grown on control tIV (Fig. 6). The number of
cells grown on tIV modified with ribose was not significantly
different from the number on glucose-modified tIV. In addition,
glycation of tIV resulted in similar increases in cell numbers when
HKM cells were grown in either 5 or 25 mi glucose. Therefore,
the effect of glycation apparently occurred in addition to and
despite the fact that the level of glucose in the media also
influenced cell growth: cells maintained in 25 m glucose in-
creased their cell numbers at an overall slower rate than cells
grown in 5 m glucose ([36] data not shown). Statistical analysis
by two-factor ANOVA confirmed that both glycation and the
concentration of glucose in the media significantly altered HKM
cell proliferation.
Morphology of cell spreading
Fig. 5. HKIVI cell spreading appearance on control or glycated tIJ/ at later time intervals. HKM cells cultured in 25 m glucose were seeded into 96-well
plates (5000 cells/well) coated with tIV (0.24 pmol/cm2) which had been previously incubated in the absence of sugar (tIV-O: 0) or in the presence of
either 50 (tIV-50: 0) or 500 m glucose (tIV-500: U) for 2 days at 29°C. After 90 minutes, cells were fixed, stained, and a minimum of 100 cells in each
of 4 wells per substrate were observed and categorized according to their spreading morphology: (A; + +) asymmetrical spreading with extensive
cytoplasmic extensions and apparent stress fiber formation, (B; +) symmetrical spreading with cytoplasmic extensions, and (C; —) symmetrical spreading
with no cytoplasmic extensions. For each substrate, the percentage of cells demonstrating the various spreading patterns was expressed as the mean
so. The effect of substrate glycation on the percentage of cells demonstrating each type of cell spreading was analyzed using single-factor analysis of
variance and Newman-Keuls multiple range tests (°P < 0.05; bar equals 15 jm).
Proliferation assays were also performed using a GBM/MM
substrate which should more closely approximate the in situ
environment of HKM cells since 40% of the isolated GBM/MM is
composed of MM [37]. Under these experimental conditions, no
significant differences were apparent in the rate of HKM cell
growth as a result of glycation (data not shown).
Discussion
We describe in this report several early and later morphologic
and functional changes of HKM cells, grown in 5 or 25 mM
glucose, following interactions with glycated tIV and intact GBM/
MM. We observed that HKM cells adhered less effectively to
glycated tIV at early time intervals and were delayed in attaining
maximal levels of adhesion compared to cells interacting with
control tIV. The nature of the adhesive interaction was also
different since antibodies which blocked the function of 13k-
containing integrins more effectively inhibited the binding of
HKM cells to glycated tIV than to control tIV. One or more of the
following mechanisms could be involved in this altered cell!
substrate interaction: (1) substrate glycation and AGE-formation
may change the affinity of a specific ligand for a cell surface
receptor by either modifying a specific lysine residue within the
binding site of the ligand or changing the conformation of the
ligand; (2) NEG adducts may directly serve as ligands for cell
surface receptors as has been described for AGEs [38] and
suggested for Amadori adducts [39, 40]; (3) NEG may alter the
spatial arrangement of ligands within the ECM and result in
perturbed cooperative interactions among cell receptors interact-
ing with the ECM.
The interaction of cells with their ECM occurs via a variety of
cell surface receptors, some of which are known to have an effect
on various aspects of cell behavior including cytoskeletal organi-
zation [41], calcium mobilization [42], protein phosphorolation
[43], and gene expression [44]. Therefore, altered cell/substrate
interactions caused by NEG may cause functional changes in
HKIvI cells. Indeed, there were differences in the cytoskeletal
organization of cells on glycated tIV, as indicated by impaired cell
surface ruffling and microspike formation after five minutes of
interaction with this glucose-modified ECM component and a
decreased ability to spread on glycated substrate which persisted
90 minutes after plating. These results indicated that at least
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Fig. 6. HKM cell proliferation as indicated by cell numbers on control or
blycated tIV HKM cells cultured in 25 m glucose were rested in growth
media containing 1% FBS for72 hours and then seeded (2000 cells/well)
into 96-well plates coated with tIV (1.2 pmoLlcm2) which had been
previously incubated in the absence of sugar (tIV-C: 0) or in the presence
of either 500 mi glucose (tIV-G: 0) or 500 mM ribose (tIV-R: ) for 5
days at 29°C. After 2 hours, the media was supplemented to 20% FBS and
the cells were incubated for 1-10 days with biweekly media changes. At
specific time intervals, cells were released and counted using an automated
cell counter. Results are expressed as the mean SD of 8 replicates and
were analyzed using single-factor analysis of variance and Newman-Keuls
multiple range tests (°P < 0.05 ANOVA; t P < 0.05 tIV-C vs. tIV-G; P
<0.10 tIV-C vs. tIV-R).
certain intracellular spreading-related events were altered by
ECM glycation.
Proliferation assays suggested that NEG may also modify
certain long-term aspects of cell behavior, since a small but
significant increase in cell numbers was observed when 11KM cells
were grown on moderately glycated tIV. Cell growth on ribose-
modified tIV, which had °°40 times more fluorescent adducts than
the glucose-modified tIV, did not result in a further increase in
cell numbers, perhaps because initial glycation events were suffi-
cient to cause the observed alteration of this cell behavior.
Another possibility may be preferential adhesion to plastic of less
modified tIV molecules due to charge or conformational changes
of their extensively glycated counterparts. Experiments performed
with tIV which was glycated in solid phase did not support this
hypothesis (data not shown). When HKM were grown on GBM/
MM, a substrate which should more closely resemble the in situ
environment of HKM cells, increasing cell numbers in response to
glycation were not observed, even though glycation altered the
interaction of cells with this substrate as indicated by an impaired
adhesion. It is possible that the intact GBMIMM contained a
different assortment of cell binding ligands for the HKM cells and
a different population of available lysine residues for glycation
when compared to isolated tIV. Therefore, the net effect of
glycation on this cell/substrate interaction, and its ultimate effect
on cell behavior, could be different from that of isolated tIV. In
diabetic nephropathy, tIV is present in increased amounts in the
expanded mesangial space [45]. Under the conditions of excess
availability and increased glycation of tIV, a slight increase in the
proliferative rate of mesangial cells could occur. In any case, the
obtained results from the in vitro proliferation experiments are
consistent with previous morphometric observations which sug-
gest that in situ mesangial cell hyperplasia should not play a major
role in the mesangial expansion of diabetes [3].
Experiments which were performed in parallel using HKM cells
grown in 5 or 25 m glucose indicate that substrate glycation
resulted in comparable changes of cell adhesion and proliferation.
Apparently, glycation of the substrate alone was sufficient to
modify several aspects of 11KM cell behavior. Since the interme-
diate and late products of the glycation reaction are stable, it is
possible that modifications could accumulate in the ECM and
influence cell behavior throughout the lifetime of the glycated
ECM components, even though glucose levels may be only
intermittently or slightly elevated. In addition, the obtained data
indicate that even very modest glucose-induced modification, with
the addition of only one mole of glucose per mole of tIV, may be
sufficient to alter certain aspects of cell behavior. These results
appear to be consistent with the findings of the recent study by the
Diabetes Control and Complications Trial Research Group which
stresses the importance of strict glycemic control in the prevention
of diabetic complications [6]. It remains to be substantiated,
however, whether the matrix glycation which occurs in situ, in the
kidneys of diabetic patients, is involved in the pathogenesis of
diabetic nephropathy.
The mechanisms by which increased glucose concentrations
result in altered cell behavior in vitro or in situ are apparently
multiple and complex. In this report we have examined the effects
of one of these possible mechanisms, glycation of the ECM and its
influence on cell behavior through altered cell/ECM interactions.
The obtained data indicate that relatively modest glucose-induced
modification of tIV and intact GBM/MM resulted in altered
adhesion and spreading. Additionally, glycated tIV slightly in-
creased the rate of cell growth. Glycation of the ECM may also
alter other aspects of cell function, including expression of ECM
components, degradation enzymes, growth factors, etc., some of
which we are currently investigating. Although differences may be
subtle, over the course of many years even small changes in cell
behavior could contribute to the significant alterations in tissue
structure and function which develop in diabetic patients. It
appears possible that altered cell functions induced by changed
cell interactions with glycated ECM might contribute, to some
extent, to the abnormal renal structure and function observed in
situ during the development of diabetic kidney disease.
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